VFE PARTNERS, LLC

VFE Partners, LLC (“VFE”) has been working with Riverview’s China-based,
affiliate company, United Media Management, LLC, in the establishment of an
approval process for Vaccinogen’s OncoVax® for colon cancer (see the
“Vaccinogen” tab below) with the Chinese sFDA.  Over the last nine months, VFE
has held “opinion leader” conferences, overseen presentations and recruited
personnel on behalf of its efforts to establish, once approved, a commercialization
effort for OncoVax® with the major Military University Hospitals based
throughout China.

The ability to commercialize OncoVax® in the Chinese markets, as well as the
markets of Taiwan and Malaysia, present VFE with an opportunity of
unprecedented value. China is the single largest colon cancer market in the world.  
Colon cancer is Taiwan’s fastest growing cancer.  Malaysia, while a small market
itself, represents an opportunity to market OncoVax® throughout the Middle
Eastern markets. Taken together, these markets represent potential revenues in the
billions of dollars annually, with large profit margins for VFE.

Riverview Capital has been instrumental in establishing VFE and conducting the
fund-raising and the formation of joint ventures both in the U.S. and in the markets
of China, Taiwan and Malaysia.   
VFE PARTNERS, LLC
CLICK TO RETURN TO TOP